Macrae Madhu, Neve Richard M, Rodriguez-Viciana Pablo, Haqq Christopher, Yeh Jennifer, Chen Chira, Gray Joe W, McCormick Frank
Cancer Research Institute and Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California 94143, USA.
Cancer Cell. 2005 Aug;8(2):111-8. doi: 10.1016/j.ccr.2005.07.005.
The EphA2 receptor tyrosine kinase is frequently overexpressed in many cancers, including 40% of breast cancers. Here, we show that EphA2 is a direct transcriptional target of the Ras-Raf-MAPK pathway and that ligand-stimulated EphA2 attenuates the growth factor-induced activation of Ras. Thus, a negative feedback loop is created that regulates Ras activity. Interestingly, the expression of EphA2 and ephrin-A1 is mutually exclusive in a panel of 28 breast cancer cell lines. We show that the MAPK pathway inhibits ephrin-A1 expression, and the ligand expression inhibits EphA2 levels contributing to the receptor-ligand reciprocal expression pattern in these cell lines. Our results suggest that an escape from the negative effects of this interaction may be important in the development of cancer.
EphA2受体酪氨酸激酶在包括40%的乳腺癌在内的许多癌症中经常过度表达。在此,我们表明EphA2是Ras-Raf-MAPK途径的直接转录靶点,并且配体刺激的EphA2会减弱生长因子诱导的Ras激活。因此,形成了一个调节Ras活性的负反馈环。有趣的是,在一组28个乳腺癌细胞系中,EphA2和ephrin-A1的表达相互排斥。我们表明MAPK途径抑制ephrin-A1的表达,而配体表达抑制EphA2水平,这促成了这些细胞系中受体-配体的相互表达模式。我们的结果表明,逃避这种相互作用的负面影响可能在癌症发展中很重要。